News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Steve Martin To Replace Reg Jones As CFO Of Stratagene; Reg Jones To Retire Effective June 30, 2005


10/19/2005 5:09:54 PM

LA JOLLA, Calif.--(BUSINESS WIRE)--May 20, 2005--Stratagene Corporation (Nasdaq:STGN), a developer, marketer and manufacturer of life science research and diagnostic products, today announced that Steve Martin, Director of Finance, will succeed Reg Jones as CFO on July 1, 2005. Mr. Jones is retiring after a 24-year career with Stratagene and Hycor Biomedical Inc., which was acquired by Stratagene on June 2, 2004. Mr. Jones will remain in a consulting capacity with Stratagene. "When Steve joined the company in May 2004, we viewed him as a potential future CFO of our company," said Joseph A. Sorge, MD, President and CEO of Stratagene. "Reg has made an enormous contribution to the Company, and now that the integration of Hycor and Stratagene is complete, and we are well on our way toward executing our growth strategies, we are positioned to smoothly transition the CFO role to Steve. I personally look forward to working with Steve, and on behalf of the entire organization thank Reg for his commitment and significant contributions to the Company."

Read at AP
Read at BioSpace.com

comments powered by Disqus
AP
BioSpace.com
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES